• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N 端干扰素 tau 突变体的特性:P26L 具有增强的活性且无毒性。

Characterization of N-terminal interferon tau mutants: P26L affords enhanced activity and lack of toxicity.

作者信息

Shorts Lynnette H, Dancz Christina E, Shupp Jeffrey W, Pontzer Carol H

机构信息

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland 20742, USA.

出版信息

Exp Biol Med (Maywood). 2004 Feb;229(2):194-202. doi: 10.1177/153537020422900208.

DOI:10.1177/153537020422900208
PMID:14734798
Abstract

Interferon (IFN)-tau is a type I IFN that is responsible for the maternal recognition of pregnancy in ruminants. This protein also has classic IFN-like properties, including antiviral, antiproliferative, and immunomodulatory functions. Using IFN-tau as a model, we examined the structural basis for the activity of type I IFNs, focusing on amino acids within helix A and the first section of the AB loop, which have been proposed as a site for receptor interaction. Six amino-acid substitutions were made that replaced a residue in ovine IFN-tau1mod with the corresponding residue in human IFN-alphaA. Receptor binding was enhanced by a P26L mutation and was reduced by a conservative lysine-to-histidine substitution at residue 34. Alterations in the antiviral and antiproliferative activities of the IFN-tau mutants were not always correlated, but both functions were maintained or enhanced relative to the wild-type IFN-tau by the proline-to-leucine mutation at residue 26. In contrast, this mutation did not affect the low in vitro cytotoxicity that is characteristic of ovine IFN-tau1mod. Thus, the IFN-tau P26L mutant may have potential as an improved IFN-based therapeutic.

摘要

干扰素(IFN)-τ是一种I型干扰素,负责反刍动物妊娠的母体识别。这种蛋白质还具有典型的干扰素样特性,包括抗病毒、抗增殖和免疫调节功能。以IFN-τ为模型,我们研究了I型干扰素活性的结构基础,重点关注A螺旋和AB环第一部分内的氨基酸,这些氨基酸被认为是受体相互作用的位点。进行了六个氨基酸替换,将绵羊IFN-τ1mod中的一个残基替换为人IFN-αA中的相应残基。P26L突变增强了受体结合,而34位残基处保守的赖氨酸到组氨酸替换则降低了受体结合。IFN-τ突变体的抗病毒和抗增殖活性的改变并不总是相关的,但相对于野生型IFN-τ,26位残基处的脯氨酸到亮氨酸突变使这两种功能得以维持或增强。相比之下,这种突变并不影响绵羊IFN-τ1mod特有的低体外细胞毒性。因此,IFN-τ P26L突变体可能具有作为改进的基于干扰素的治疗药物的潜力。

相似文献

1
Characterization of N-terminal interferon tau mutants: P26L affords enhanced activity and lack of toxicity.N 端干扰素 tau 突变体的特性:P26L 具有增强的活性且无毒性。
Exp Biol Med (Maywood). 2004 Feb;229(2):194-202. doi: 10.1177/153537020422900208.
2
Structure-function relationships in the interferon-tau (IFN-tau). Changes in receptor binding and in antiviral and antiproliferative activities resulting from site-directed mutagenesis performed near the carboxyl terminus.干扰素 -τ(IFN-τ)中的结构 - 功能关系。通过在羧基末端附近进行定点诱变所导致的受体结合以及抗病毒和抗增殖活性的变化。
J Biol Chem. 1994 Oct 7;269(40):24826-33.
3
Structure/function studies with interferon tau: evidence for multiple active sites.
J Interferon Res. 1994 Jun;14(3):133-41. doi: 10.1089/jir.1994.14.133.
4
Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities.干扰素τ和α对I型干扰素受体的差异性识别导致了它们不同的细胞毒性。
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12270-4. doi: 10.1073/pnas.92.26.12270.
5
Amino acid differences in interferon-tau (IFN-τ) of Bos taurus Coreanae and Holstein.中朝黄牛和荷斯坦奶牛干扰素 -τ 的氨基酸差异。
Cytokine. 2012 Aug;59(2):273-9. doi: 10.1016/j.cyto.2012.03.031. Epub 2012 May 10.
6
A type I ovine interferon with limited similarity to IFN-alpha, IFN-omega and IFN-tau: gene structure, biological properties and unusual species specificity.
Biochim Biophys Acta. 1996 May 2;1294(1):55-62. doi: 10.1016/0167-4838(95)00262-6.
7
The cross-species antiviral activities of different IFN-tau subtypes on bovine, murine, and human cells: contradictory evidence for therapeutic potential.
J Interferon Cytokine Res. 1999 Dec;19(12):1335-41. doi: 10.1089/107999099312795.
8
Loss of the signature six carboxyl amino acid tail from ovine interferon-tau does not affect biological activity.绵羊干扰素τ特征性的六个羧基氨基酸尾缺失并不影响其生物活性。
Biol Reprod. 1998 Jun;58(6):1463-8. doi: 10.1095/biolreprod58.6.1463.
9
Effect of variants of interferon-tau with mutations near the carboxyl terminus on luteal life span in sheep.羧基末端附近发生突变的干扰素-τ变体对绵羊黄体寿命的影响。
Biol Reprod. 1997 Jan;56(1):214-20. doi: 10.1095/biolreprod56.1.214.
10
The antiproliferative and antiviral activities of IFN-tau variants in human cells.干扰素τ变体在人细胞中的抗增殖和抗病毒活性。
J Interferon Cytokine Res. 1997 Dec;17(12):769-79. doi: 10.1089/jir.1997.17.769.

引用本文的文献

1
IFN-zeta/ limitin: a member of type I IFN with mild lympho-myelosuppression.干扰素-ζ/极限素:一种具有轻度淋巴细胞-骨髓抑制作用的I型干扰素成员。
J Cell Mol Med. 2005 Apr-Jun;9(2):244-54. doi: 10.1111/j.1582-4934.2005.tb00353.x.
2
Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity.干扰素-ζ/限制素:一种新型I型干扰素,具有窄范围的生物活性。
Int J Hematol. 2004 Nov;80(4):325-31. doi: 10.1532/ijh97.04087.